Feng Xiao

2.2k total citations
62 papers, 1.9k citations indexed

About

Feng Xiao is a scholar working on Molecular Biology, Biological Psychiatry and Biomedical Engineering. According to data from OpenAlex, Feng Xiao has authored 62 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Biological Psychiatry and 9 papers in Biomedical Engineering. Recurrent topics in Feng Xiao's work include Tryptophan and brain disorders (15 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers) and Alzheimer's disease research and treatments (8 papers). Feng Xiao is often cited by papers focused on Tryptophan and brain disorders (15 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers) and Alzheimer's disease research and treatments (8 papers). Feng Xiao collaborates with scholars based in China, United States and Saint Kitts and Nevis. Feng Xiao's co-authors include Ying Jia, Tingxu Yan, Bo Wu, Bosai He, Yusuf A. Hannun, Kaishun Bi, Mengjie Xu, Kaishun Bi, Wei Wang and Jialong Fan and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Nano Letters.

In The Last Decade

Feng Xiao

60 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Xiao China 28 849 280 245 222 216 62 1.9k
Yanyan Yin China 28 649 0.8× 273 1.0× 210 0.9× 236 1.1× 118 0.5× 73 1.8k
Chuwen Li China 28 777 0.9× 145 0.5× 97 0.4× 139 0.6× 183 0.8× 79 1.9k
Yingliang Wu China 32 1.1k 1.3× 135 0.5× 117 0.5× 124 0.6× 98 0.5× 130 2.9k
Faheem Hyder Pottoo Saudi Arabia 31 754 0.9× 247 0.9× 89 0.4× 277 1.2× 90 0.4× 122 2.5k
Di Zhao China 27 816 1.0× 110 0.4× 110 0.4× 147 0.7× 227 1.1× 116 1.9k
Shrikant Kukreti India 23 1.6k 1.9× 162 0.6× 133 0.5× 471 2.1× 101 0.5× 101 3.3k
Jhi Biau Foo Malaysia 26 1.0k 1.2× 117 0.4× 109 0.4× 215 1.0× 123 0.6× 65 2.0k
Maggie Pui Man Hoi Macao 31 1.3k 1.5× 139 0.5× 96 0.4× 294 1.3× 292 1.4× 94 2.7k

Countries citing papers authored by Feng Xiao

Since Specialization
Citations

This map shows the geographic impact of Feng Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Xiao more than expected).

Fields of papers citing papers by Feng Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Xiao. The network helps show where Feng Xiao may publish in the future.

Co-authorship network of co-authors of Feng Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Xiao. A scholar is included among the top collaborators of Feng Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Xiao. Feng Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Tingting, Chao Jin, Jing Sun, et al.. (2024). Paroxetine alleviates dendritic cell and T lymphocyte activation via GRK2-mediated PI3K–AKT signaling in rheumatoid arthritis. Chinese Medical Journal. 138(4). 441–451. 5 indexed citations
2.
Hou, Qinghong, Lulu Wang, Feng Xiao, et al.. (2022). Dual targeting nanoparticles for epilepsy therapy. Chemical Science. 13(43). 12913–12920. 23 indexed citations
3.
Yan, Tingxu, Bing Liu, Bo Wu, et al.. (2020). Schisandra chinensis ameliorates depressive‐like behaviors by regulating microbiota‐gut‐brain axis via its anti‐inflammation activity. Phytotherapy Research. 35(1). 289–296. 47 indexed citations
4.
Chen, Song, Renyu Ding, Ziwei Hu, et al.. (2020). MicroRNA-34a Inhibition Alleviates Lung Injury in Cecal Ligation and Puncture Induced Septic Mice. Frontiers in Immunology. 11. 1829–1829. 28 indexed citations
5.
Liu, Bin, Wenmiao Wang, Wenmiao Wang, et al.. (2019). RBC membrane camouflaged prussian blue nanoparticles for gamabutolin loading and combined chemo/photothermal therapy of breast cancer. Biomaterials. 217. 119301–119301. 167 indexed citations
6.
Xu, Mengjie, Tingxu Yan, Kaiyue Fan, et al.. (2019). Polysaccharide of Schisandra Chinensis Fructus ameliorates cognitive decline in a mouse model of Alzheimer's disease. Journal of Ethnopharmacology. 237. 354–365. 58 indexed citations
7.
Zhang, Mei, Shanshan Hu, Juan Tao, et al.. (2019). Ginsenoside compound-K inhibits the activity of B cells through inducing IgD-B cell receptor endocytosis in mice with collagen-induced arthritis. Inflammopharmacology. 27(4). 845–856. 21 indexed citations
8.
Zhang, Jingying, Jinyu Wang, Tingxu Yan, et al.. (2019). The anti-nephritic activity of a polysaccharide from okra (Abelmoschus esculentus (L.) Moench) via modulation of AMPK-Sirt1-PGC-1α signaling axis mediated anti-oxidative in type 2 diabetes model mice. International Journal of Biological Macromolecules. 140. 568–576. 59 indexed citations
9.
Tang, Hao, Yijin Wu, Feng Xiao, et al.. (2019). Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis. Biomedicine & Pharmacotherapy. 119. 109432–109432. 15 indexed citations
10.
Fan, Jialong, Qingxin Liu, Chunyi Tong, et al.. (2019). An ultrasensitive and simple assay for the Hepatitis C virus using a reduced graphene oxide-assisted hybridization chain reaction. The Analyst. 144(13). 3972–3979. 25 indexed citations
11.
Yu, Qi, Tingxu Yan, Feng Xiao, et al.. (2019). Effect of Alpinia oxyphylla—Schisandra chinensis herb pair on inflammation and apoptosis in Alzheimer's disease mice model. Journal of Ethnopharmacology. 237. 28–38. 39 indexed citations
12.
Wang, Yunlong, Mengshi Wang, Mengjie Xu, et al.. (2018). Nootkatone, a neuroprotective agent from Alpiniae Oxyphyllae Fructus, improves cognitive impairment in lipopolysaccharide-induced mouse model of Alzheimer's disease. International Immunopharmacology. 62. 77–85. 71 indexed citations
13.
Wu, Yijin, Mingyi Zhao, Jian Wang, et al.. (2018). Absorption and efflux characteristics of CP-25 in plasma and peripheral blood mononuclear cells of rats by UPLC-MS/MS. Biomedicine & Pharmacotherapy. 108. 1651–1657. 7 indexed citations
14.
Wang, Mengshi, Kaiyue Fan, Tongde Li, et al.. (2017). Ameliorating effect of Alpinia oxyphylla—Schisandra chinensis herb pair on cognitive impairment in a mouse model of Alzheimer’s disease. Biomedicine & Pharmacotherapy. 97. 128–135. 25 indexed citations
15.
Xu, Mengjie, Liwen Hu, Tingxu Yan, et al.. (2017). Schisandrin rescues depressive-like behaviors induced by chronic unpredictable mild stress via GDNF/ERK1/2/ROS and PI3K/AKT/NOX signaling pathways in mice. Psychiatry Research. 257. 230–237. 32 indexed citations
17.
Xiao, Feng, et al.. (2015). Determination of the contents of vitamin C and its derivatives in cosmetics by high performance liquid chromatography. Chinese Journal of Chromatography. 33(7). 771–771. 2 indexed citations
18.
Xiao, Feng, et al.. (2011). Emergency medicine in China: present and future. World Journal of Emergency Medicine. 2(4). 245–245. 32 indexed citations
19.
Carden, Donna L., et al.. (2005). Outcomes of patients not transported after calling 911. Journal of Emergency Medicine. 28(4). 449–454. 22 indexed citations
20.
Xiao, Feng, Kevin Becker, Sloan Stribling, Kevin G. Peters, & Yusuf A. Hannun. (2000). Regulation of Receptor-mediated Protein Kinase C Membrane Trafficking by Autophosphorylation. Journal of Biological Chemistry. 275(22). 17024–17034. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026